Literature DB >> 6319444

Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans.

R Marcus, P Madvig, G Young.   

Abstract

We evaluated parathyroid function in 158 normal subjects, aged 23-85 yr. Calcium, phosphorus, creatinine, and cAMP were measured in blood and urine in the fasting state and after a 1-g oral calcium challenge. Serum immunoreactive PTH (iPTH) was measured with a goat antiserum developed against human PTH, using (43Tyr) human PTH-(44-68) as tracer and standards. With age, a decrease in total serum Ca (r = -0.14; P less than 0.05) was attributable to a fall in serum albumin (r = -0.40; P less than 0.001). Creatinine clearance fell from 124 ml/min at age 20 yr to 61 ml/min at age 80 yr (r = -0.44; P less than 0.001). iPTH rose with age in men (r = 0.21; P less than 0.05) and women (r = 0.31; P less than 0.001) from 29 pg/ml at age 20 yr to 48 pg/ml at 80 yr. iPTH was also correlated with creatinine clearance (r = -0.32; P less than 0.001. When renal function was controlled in the analysis, the regression of iPTH with age was no longer significant. Other significant correlations with age include a decrease in renal phosphorus reabsorption (r = -0.17; P less than 0.05) and an increase in urinary nephrogenous cAMP excretion (r = 0.34; P less than 0.01). The rise in nephrogenous cAMP was not accompanied by a change in total urinary cAMP, since plasma, and therefore filtered, cAMP decreased with age. Basal calcium excretion was stable, but the calciuric response to oral calcium decreased (r = -0.27; P less than 0.01). We conclude that loss of renal function is the major cause of rising iPTH levels with age.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319444     DOI: 10.1210/jcem-58-2-223

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey.

Authors:  J M Paik; W R Farwell; E N Taylor
Journal:  Osteoporos Int       Date:  2011-09-20       Impact factor: 4.507

2.  The effect of age on the renal response to PTH infusion.

Authors:  M A Naafs; H R Fischer; G Koorevaar; W H Hackeng; W Schopman; J Silberbusch
Journal:  Calcif Tissue Int       Date:  1987-11       Impact factor: 4.333

3.  Causes of secondary hyperparathyroidism in a healthy population: the Tromsø study.

Authors:  Farahnaz Saleh; Rolf Jorde; Johan Sundsfjord; Egil Haug; Yngve Figenschau
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

4.  The effects of menopause and estrogen replacement therapy on the renal handling of calcium.

Authors:  S Adami; D Gatti; F Bertoldo; M Rossini; A Fratta-Pasini; N Zamberlan; E Facci; V Lo Cascio
Journal:  Osteoporos Int       Date:  1992-07       Impact factor: 4.507

Review 5.  Lessons from second- and third-generation parathyroid hormone assays in primary hyperparathyroidism.

Authors:  J C Souberbielle; P Boudou; C Cormier
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

Review 6.  Vitamin D insufficiency as a determinant of hip fractures.

Authors:  J M Quesada-Gómez; J Alonso; R Bouillon
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

7.  Effect of menopause and aging on serum total and ionized calcium and protein concentrations.

Authors:  L J Sokoll; B Dawson-Hughes
Journal:  Calcif Tissue Int       Date:  1989-03       Impact factor: 4.333

Review 8.  Osteoporosis in the older woman: a reappraisal.

Authors:  N M Resnick; S L Greenspan
Journal:  Public Health Rep       Date:  1989 Sep-Oct       Impact factor: 2.792

9.  Acute suppression of bone turnover with calcium infusion in persons with spinal cord injury.

Authors:  William A Bauman; Run-Lin Zhang; Nancy Morrison; Ann M Spungen
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

10.  Differential effects of dietary calcium augmentation and hormone replacement therapy on bone turnover and serum levels of calcitrophic hormones.

Authors:  J F Aloia; A Vaswani; J K Yeh; L Russo
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.